DiviDrip · BDTX

BDTX — Black Diamond Therapeutics, Inc.

BDTX is Black Diamond Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.14. Market cap: $123M. Capital Quality Rank: 51/100 — Stagnant mediocrity.

Stock snapshot

Price$2.14
Market cap$123M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)51 / 100 · Stagnant mediocrity
ROIC (TTM)10.8%
Shareholder buyback yield-4.40%
Altman Z-score zoneDistress

About BDTX

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Listed2020Employees21HQCambridge, MASectorHealthcareWebsiteblackdiamondtherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside BDTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is BDTX's current stock price?

BDTX (Black Diamond Therapeutics, Inc.) is currently trading at $2.14.

Does BDTX pay a dividend?

BDTX (Black Diamond Therapeutics, Inc.) does not currently pay a regular dividend.

What is BDTX's Capital Quality Rank?

BDTX has a Capital Quality Rank of 51/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track BDTX in DiviDrip

Add BDTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow